Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript
Source: SeekingAlpha
2025-12-02 17:53:25 ET
Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data December 2, 2025 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript
Jasper Therapeutics Inc.
NASDAQ: JSPR
JSPR Trading
-6.25% G/L:
$1.35 Last:
79,076 Volume:
$1.43 Open:
JSPR Latest News
February 24, 2026 04:30:00 pm
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
January 08, 2026 07:00:00 am
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
JSPR Stock Data
$36,659,091
21,939,487
1.06%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
